Argus
•
Sep 02, 2026
COLL: Lowering target price to $23.00
Summary
Collegium Pharmaceutical Inc is a specialty pharmaceutical company.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
PTCT: Lowering target price to $67.00
Sep 02, 2026
•
PTCT
ANIP: Lowering target price to $68.00
Sep 02, 2026
•
ANIP
AMPH: Raising target price to $24.00
Sep 02, 2026
•
AMPH
SUPN: Lowering target price to $42.00
Sep 02, 2026
•
SUPN
PTGX: Lowering target price to $154.00
Sep 02, 2026
•
PTGX
